3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Oligometastatic Prostate Cancer (OMPC)
1
Metastatic Neuroendocrine Prostate Cancer
1
Advanced Gastroenteropancreatic Neuroendocrine Tumor
1
Interventions
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
avelumab
1
aldesleukin
1
Nivolumab
1
Cyclophosphamide
1
Axitinib
1
Antineoplastic Protocols
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
Lutetium-177
×
30 days
×
Clear all
No trials found.